Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Westerink

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
JMIR Research Protocols|June 16, 2026
Prevalence of and Risk Factors for Metabolic Syndrome, Vascular Damage, and Accelerated Aging (MetVasA) After Pediatric Hematopoietic Stem Cell Transplantation for Hematological Malignancy: Protocol for a Cross-Sectional Cohort StudyLisa J Asbroek, Helena Jh van der Pal, Marta Fiocco, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 9, 2025
2023 European Society of Cardiology guidelines for the management of cardiovascular disease in patients with diabetes : Statement of endorsement by the NVVCFabrice M A C Martens, Frank L J Visseren, Jan Westerink, et al.
Frontiers in Physiology|March 12, 2021
Impaired Cytoskeletal and Membrane Biophysical Properties of Acanthocytes in Hypobetalipoproteinemia - A Case StudyAnne-Sophie Cloos, Laura G M Daenen, Mauriane Maja, et al.
Plos One|January 6, 2023
Thoracic outlet syndrome (TROTS) registry: A study protocol for the primary upper extremity deep venous thrombosis sectionLudo Schropp, Robert J C M F de Kleijn, Jan Westerink, et al.
Journal of Personalized Medicine|August 6, 2021
Visceral Adipose Tissue and Different Measures of Adiposity in Different Severities of Diffuse Idiopathic Skeletal HyperostosisNetanja I Harlianto, Jan Westerink, Wouter Foppen, et al.
Atherosclerosis|September 12, 2020
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levelsKang H Zheng, Yannick Kaiser, Casper C van Olden, et al.
Circulation|September 30, 2016
Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationLotte Kaasenbrood, S Matthijs Boekholdt, Yolanda van der Graaf, et al.
European Journal of Preventive Cardiology|April 8, 2024
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM modelMarga A G Helmink, Sanne A E Peters, Jan Westerink, et al.
Plos One|July 14, 2020
Intimal and medial calcification in relation to cardiovascular risk factorsSabine R Zwakenberg, Pim A de Jong, Eva J Hendriks, et al.
Diabetes, Obesity & Metabolism|March 8, 2024
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D modelMarga A G Helmink, Steven H J Hageman, Björn Eliasson, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
JMIR Research Protocols|June 16, 2026
Prevalence of and Risk Factors for Metabolic Syndrome, Vascular Damage, and Accelerated Aging (MetVasA) After Pediatric Hematopoietic Stem Cell Transplantation for Hematological Malignancy: Protocol for a Cross-Sectional Cohort StudyLisa J Asbroek, Helena Jh van der Pal, Marta Fiocco, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 9, 2025
2023 European Society of Cardiology guidelines for the management of cardiovascular disease in patients with diabetes : Statement of endorsement by the NVVCFabrice M A C Martens, Frank L J Visseren, Jan Westerink, et al.
Frontiers in Physiology|March 12, 2021
Impaired Cytoskeletal and Membrane Biophysical Properties of Acanthocytes in Hypobetalipoproteinemia - A Case StudyAnne-Sophie Cloos, Laura G M Daenen, Mauriane Maja, et al.
Plos One|January 6, 2023
Thoracic outlet syndrome (TROTS) registry: A study protocol for the primary upper extremity deep venous thrombosis sectionLudo Schropp, Robert J C M F de Kleijn, Jan Westerink, et al.
Journal of Personalized Medicine|August 6, 2021
Visceral Adipose Tissue and Different Measures of Adiposity in Different Severities of Diffuse Idiopathic Skeletal HyperostosisNetanja I Harlianto, Jan Westerink, Wouter Foppen, et al.
Atherosclerosis|September 12, 2020
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levelsKang H Zheng, Yannick Kaiser, Casper C van Olden, et al.
Circulation|September 30, 2016
Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationLotte Kaasenbrood, S Matthijs Boekholdt, Yolanda van der Graaf, et al.
European Journal of Preventive Cardiology|April 8, 2024
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM modelMarga A G Helmink, Sanne A E Peters, Jan Westerink, et al.
Plos One|July 14, 2020
Intimal and medial calcification in relation to cardiovascular risk factorsSabine R Zwakenberg, Pim A de Jong, Eva J Hendriks, et al.
Diabetes, Obesity & Metabolism|March 8, 2024
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D modelMarga A G Helmink, Steven H J Hageman, Björn Eliasson, et al.
Pageof 12